MPN
MPN
Advertisement
Dustin SamplesHematology & Blood Cancer | January 6, 2023
Interprofessional team-based care is the standard for patients undergoing HSCT. But who belongs on the team?
Read More
Dustin SamplesMPN | December 14, 2022
Patients with MPN who had an AMI are analyzed for risk of additional major adverse cardiovascular events and bleeding.
Dustin SamplesMPN | December 14, 2022
Do cytoreductive therapies affect quality of life for patients with MPN in different ways?
Dustin SamplesMPN | December 14, 2022
Researchers evaluated risk factors for ATEs and VTEs. Their scoring system performed better than the current standard.
Dustin SamplesMPN | December 14, 2022
The phase II study results are in. Researchers will now test rusfertide against placebo in a randomized clinical trial.
Dustin SamplesMPN | December 14, 2022
Researchers determined the incidence of TEAEs related to rusfertide in patients with PV.
Patrick DalyMPN | December 20, 2021
Essential thrombocytosis (ET), polycythemia vera (PV), and primary myelofibrosis (PM) are BCR-ABL–negative ...
Patrick DalyMPN | December 20, 2021
According to Alexander Chan, MD, and colleagues from the Department of Pathology at the Memorial Sloan Kettering Cancer ...
Patrick DalyMPN | December 20, 2021
In patients with polycythemia vera (PV), arterial thrombosis (AT) and venous thrombosis (VT) events are common complications ...
Patrick DalyMPN | December 20, 2021
Polycythemia vera (PV) is subject to the chronic inflammation commonly observed in other myeloproliferative neoplasms. Recent ...
Patrick DalyMPN | December 7, 2021
In a follow-up to the randomized controlled trial APL0406, researchers compared long-term health-related quality of life of ...
Patrick DalyMPN | December 7, 2021
A phase I study tested low dose clofarabine with escalating doses of entinostat in adults with Philadelphia ...
Patrick DalyMPN | December 7, 2021
A study published in the Journal of Clinical Oncology found that therapy with two doses of imetelstat appears to have ...
Patrick DalyMPN | December 7, 2021
In an a study published in Leukemia Research, researchers trialed the combination of dociparstat sodium (DSTAT) and ...
Ariel JonesMPN | October 25, 2021
Findings from a report published in Blood Advances suggest that certain germline variants in DNA repair pathway genes, ...
Ariel JonesMPN | September 28, 2021
Anticoagulation with vitamin K antagonists (VKAs) such as warfarin has been the standard of care for thrombosis in patients ...
Ariel JonesMPN | August 31, 2021
In a case series published in the American Journal of Hematology, authors evaluated the relationship between ...
Ariel JonesMPN | July 20, 2021
A study recently published in the Journal of Clinical Nursing explored the experiences of daily living and identified ...
Ariel JonesMPN | May 26, 2021
In patients with myeloproliferative neoplasms (MPNs), presence of somatic mutations in the hematopoietic transcription factor ...
Ariel JonesMPN | May 12, 2021
Venetoclax combined with a hypomethylating agent (HMA) has emerged as an effective treatment regimen for acute myeloid ...
Advertisement
Advertisement
Advertisement